FDA may reject Auxilium drug application, TheStreet says TheStreet's Adam Feuerstein predicts that the FDA will reject an application for Auxilium Pharmaceuticals' drug Xiaflex , but added his conviction level is "5-6 out of 10 -- so not much more than a toss up." Reference Link
News For AUXL From The Last 14 Days
Check below for free stories on AUXL the last two weeks.
Auxilium Xiaflex likely to be approved, says Stifel Stifel thinks there is at least an 80% chance that Auxilium's Xiaflex for Peyronie’s disease will be approved by the FDA. Noting that the drug has a December 6 PDUFA date, Stifel believes the stock can "trade well into the mid-$20s" if the drug is approved. The firm keeps a Buy rating on the stock.